- Home
- ACP vs TCMD Comparison
ACP vs TCMD Comparison
Compare ACP & TCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ACP | TCMD |
|---|---|---|
| Founded | 2010 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 663.7M | 533.5M |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | ACP | TCMD |
|---|---|---|
| Price | $5.21 | $25.40 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $36.00 |
| AVG Volume (30 Days) | ★ 439.8K | 272.1K |
| Earning Date | 01-01-0001 | 05-04-2026 |
| Dividend Yield | ★ 17.79% | N/A |
| EPS Growth | N/A | ★ 17.14 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $11.60 |
| Revenue Next Year | N/A | $9.14 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.99 | $9.42 |
| 52 Week High | $5.99 | $37.77 |
Technical Indicators
Market Signals| Indicator | ACP | TCMD |
|---|---|---|
| Relative Strength Index (RSI) | 38.44 | 54.69 |
| Support Level | $5.13 | $22.78 |
| Resistance Level | $5.46 | $26.22 |
| Average True Range (ATR) | 0.07 | 1.05 |
| MACD | -0.02 | 0.10 |
| Stochastic Oscillator | 14.00 | 75.70 |
Price Performance
Historical ComparisonAbout ACP abrdn Income Credit Strategies Fund
abrdn Income Credit Strategies Fund is a diversified, closed-end management investment company. Its investment objective is to seek a high level of current income with a secondary objective of capital appreciation. It predominantly invests in debt and loan instruments of issues that operate in a variety of industries and geographic regions.
About TCMD Tactile Systems Technology Inc.
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system, provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.